InHealth awards two research grants to Stanford University

October 13, 2006

Washington, D.C., October 13, 2006 -The Institute for Health Technology Studies (InHealth) has awarded one-year research grants to two teams at Stanford University. One will examine the socio-economic value of MRI and CT imaging technology. The other will document the current regulatory and commercialization processes required of new medical technologies. The grants, totaling $538,207, are part of InHealth's continuing research mission to bring objective data and perspective to understanding the impact of medical technology on patients and the health care industry.

The first study, "The Diffusion of Imaging Technologies, Health Care Costs and Quality," will investigate the relationships among the availability of advanced diagnostic imaging services, usage, patient outcomes and health care spending. The second study, "Medical Device Development Models," will document how medical devices are approved and enhanced, pre- and post-market, including the role of the Food and Drug Administration. In addition, the study will clarify the different paths followed by medical devices, pharmaceuticals and biotech products. Results from both studies are anticipated by fall 2007.

"Critical discussions about the nation's health care system should be based on objective data rather than political opinion. Our goal is to help uncover that data so that decision-makers have a fuller understanding of how to legislate and regulate in the health and economic interests of patients and their families," said Martyn Howgill, Executive Director of InHealth.

Examining the Growth and Impact of Advanced Imaging Technologies

Stanford investigators will look at the effects of increased availability of MRI and CT technologies on the cost and quality of health care and whether costs are offset by benefits. No such studies are currently available. The researchers will collect data from 1992-2004 on the availability of MRI and CT services in different regions of the U.S., insurance claims for these services, and the use and spending on other imaging services and medical treatments (e.g., non-imaging procedures and procedures prompted by imaging results). The team will then correlate the data to draw conclusions about the costs and benefits of imaging technology to society, particularly the relationships among expanded use of imaging, spending, quality and patient care.

According to Howgill, diagnostic imaging tests are vital for accurate and early diagnosis of disease and play a crucial role in determining which medical treatments are subsequently prescribed by physicians. Yet expenditures on imaging tests are a fraction of the cost of the care that is then provided. Howgill expects the study to have an impact on understanding diagnostic imaging's role in medical care and on regulatory policies that affect diagnostic imaging facilities.

Laurence Baker, Ph.D., chief of Health Services Research and associate professor of health research and policy at Stanford University Medical School, is the principal investigator. Scott Atlas, M.D., professor of radiology and chief of neuroradiology at Stanford, and Christopher Afendulis, Ph.D., a lecturer in the Department of Health Care Policy at Harvard Medical School, are co-investigators.

Examining the Medical Device Commercialization Process

The device development study aims to examine how medical technology is brought to market, approved for use and subsequently enhanced over time. The team will build a model specific to medical technology, making clear distinctions from the drug development process. Researchers anticipate study findings will be of value to current and future government initiatives, such as the FDA's Critical Path Initiative to enhance the efficiency and efficacy of the regulatory process for public benefit.

"Medical devices require a broader range of development cycles than drugs to achieve full commercialization. This distinction can be ambiguous but it has a significant impact on the timely availability of safe and effective technologies for patients and practitioners," Howgill said.
-end-
John Linehan, Ph.D., Consulting Professor of Bioengineering in Stanford University's Program in Biodesign and the Department of Bioengineering is the principal investigator. Elisabeth Paté-Cornell, Ph.D., co-investigator, is the Burt and Deedee McMurtry Professor of Engineering and Professor and Chair of the Department of Management Science and Engineering at Stanford University. Paul Yock, M.D., also a co- investigator, is the Martha Meier Weiland Professor of Medicine and Mechanical Engineering (by courtesy) and Co-Chair of Stanford's new Department of Bioengineering.

The two new Stanford University grants represent the most recent research awards from InHealth to support studies exploring the impact of innovative medical technology on socio-econmic issues including patient care, quality of life and cost efficiencies. InHealth-funded research is currently underway by teams at Duke University, Harvard University/Beth Israel Deaconness Medical Center and the University of Pennsylvania.

About InHealth (www.inhealth.org)

Launched in 2004, The Institute for Health Technology Studies (InHealth) is a 501(c) 3 nonprofit organization that researches the social and economic impact of medical technology. InHealth is funded by unrestricted philanthropic gifts and funds research grants and educational forums. It adheres to the International Committee of Medical Journal Editors' principles of sponsorship.

Innsbruck Medical University

Related Health Care Articles from Brightsurf:

Study evaluates new World Health Organization Labor Care Guide for maternity care providers
The World Health Organization developed the new Labor Care Guide to support clinicians in providing good quality, women-centered care during labor and childbirth.

Six ways primary care "medical homes" are lowering health care spending
New analysis of 394 U.S. primary care practices identifies the aspects of care delivery that are associated with lower health care spending and lower utilization of emergency care and hospital admissions.

Modifiable health risks linked to more than $730 billion in US health care costs
Modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to over $730 billion in health care spending in the US in 2016, according to a study published in The Lancet Public Health.

Spending on primary care vs. other US health care expenditures
National health care survey data were used to assess the amount of money spent on primary care relative to other areas of health care spending in the US from 2002 to 2016.

MU Health Care neurologist publishes guidance related to COVID-19 and stroke care
A University of Missouri Health Care neurologist has published more than 40 new recommendations for evaluating and treating stroke patients based on international research examining the link between stroke and novel coronavirus (COVID-19).

Large federal program aimed at providing better health care underfunds primary care
Despite a mandate to help patients make better-informed health care decisions, a ten-year research program established under the Affordable Care Act has funded a relatively small number of studies that examine primary care, the setting where the majority of patients in the US receive treatment.

International medical graduates care for Medicare patients with greater health care needs
A study by a Massachusetts General Hospital research team indicates that internal medicine physicians who are graduates of medical schools outside the US care for Medicare patients with more complex medical needs than those cared for by graduates of American medical schools.

The Lancet Global Health: Improved access to care not sufficient to improve health, as epidemic of poor quality care revealed
Of the 8.6 million deaths from conditions treatable by health care, poor-quality care is responsible for an estimated 5 million deaths per year -- more than deaths due to insufficient access to care (3.6 million) .

Under Affordable Care Act, Americans have had more preventive care for heart health
By reducing out-of-pocket costs for preventive treatment, the Affordable Care Act appears to have encouraged more people to have health screenings related to their cardiovascular health.

High-deductible health care plans curb both cost and usage, including preventive care
A team of researchers based at IUPUI has conducted the first systematic review of studies examining the relationship between high-deductible health care plans and the use of health care services.

Read More: Health Care News and Health Care Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.